What is Dimension Inx?
Dimension Inx is pioneering the future of medicine through its advanced biofabrication technology. The company's 3D-Painting Materials Design and Manufacturing System is engineered for versatility, manufacturability, and affordability, aiming to accelerate the widespread adoption of regenerative medical products. By combining expertise in materials science and tissue engineering, Dimension Inx collaborates with leading clinicians, surgeons, and medical product companies to develop novel solutions that fundamentally alter how human diseases and conditions are treated. The company's focus on creating the next frontier in medicine positions it at the forefront of therapeutic innovation.
How much funding has Dimension Inx raised?
Dimension Inx has raised a total of $15.2M across 3 funding rounds:
Unspecified
$35K
Angel/Seed
$3.2M
Series A
$12M
Unspecified (2019): $35K, investors not publicly disclosed
Angel/Seed (2020): $3.2M led by Better Ventures, KdT Ventures,, and Rise of the Rest Seed Fund
Series A (2023): $12M supported by Prime Movers Lab and KdT Ventures
Key Investors in Dimension Inx
Prime Movers Lab
Prime Movers Lab is a venture capital firm dedicated to funding breakthrough scientific startups that aim to transform industries and improve lives. They focus on supporting founders with innovative ideas and a growth mentality, particularly in early-stage scientific ventures.
KdT Ventures
KdT Ventures specializes in early-stage frontier science investing, focusing on transformative technologies in medicine, chemicals, and materials. They are known for leading or co-leading pre-seed and seed funding rounds for innovative platforms.
Better Ventures
Better Ventures is a mission-driven venture capital firm investing in early-stage startups that leverage science and technology for a sustainable economy. Their focus areas include improving human health and equipping tomorrow's workforce with innovative solutions.
What's next for Dimension Inx?
With the recent influx of major strategic investment, Dimension Inx is poised for significant expansion and further development of its biofabrication platform. The company's Series A funding, alongside earlier seed capital, suggests a strategic move towards scaling operations and accelerating the commercialization of its regenerative medical solutions. Future endeavors will likely focus on clinical validation, expanding manufacturing capabilities, and forging new partnerships within the healthcare ecosystem. This sustained backing from prominent investors signals a strong commitment to advancing the company's mission of transforming patient care through cutting-edge biofabrication.
See full Dimension Inx company page
